Cita APA (7a ed.)

Klepsch, V., Hermann-Kleiter, N., Do-Dinh, P., Jakic, B., Offermann, A., Efremova, M., . . . Baier, G. (2018). Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. Nature Portfolio.

Cita Chicago Style (17a ed.)

Klepsch, Victoria, et al. Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade. Nature Portfolio, 2018.

Cita MLA (8a ed.)

Klepsch, Victoria, et al. Nuclear Receptor NR2F6 Inhibition Potentiates Responses to PD-L1/PD-1 Cancer Immune Checkpoint Blockade. Nature Portfolio, 2018.